339 related articles for article (PubMed ID: 34233966)
1. Study protocol of a phase 2, dual-centre, randomised, controlled trial evaluating the effectiveness of probiotic and egg oral immunotherapy at inducing desensitisation or sustained unresponsiveness (remission) in participants with egg allergy compared with placebo (Probiotic Egg Allergen Oral Immunotherapy for Treatment of Egg Allergy: PEAT study).
Loke P; Chebar Lozinsky A; Orsini F; Wong LS; Leung AS; Tham EH; Lopata AL; Shek LP; Tang ML;
BMJ Open; 2021 Jul; 11(7):e044331. PubMed ID: 34233966
[TBL] [Abstract][Full Text] [Related]
2. Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study).
Chebar Lozinsky A; Loke P; Orsini F; O'Sullivan M; L Prescott S; Gold MS; Quinn P; DunnGalvin A; Lk Tang M;
BMJ Open; 2020 Sep; 10(9):e035871. PubMed ID: 32912942
[TBL] [Abstract][Full Text] [Related]
3. Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.
Loke P; Orsini F; Lozinsky AC; Gold M; O'Sullivan MD; Quinn P; Lloyd M; Ashley SE; Pitkin S; Axelrad C; Metcalfe JR; Su EL; Tey D; Robinson MN; Allen KJ; Prescott SL; Galvin AD; Tang MLK;
Lancet Child Adolesc Health; 2022 Mar; 6(3):171-184. PubMed ID: 35123664
[TBL] [Abstract][Full Text] [Related]
4. Administration of a probiotic with peanut oral immunotherapy: A randomized trial.
Tang ML; Ponsonby AL; Orsini F; Tey D; Robinson M; Su EL; Licciardi P; Burks W; Donath S
J Allergy Clin Immunol; 2015 Mar; 135(3):737-44.e8. PubMed ID: 25592987
[TBL] [Abstract][Full Text] [Related]
5. Allergen-specific oral immunotherapy for peanut allergy.
Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
[TBL] [Abstract][Full Text] [Related]
6. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial.
Anagnostou K; Islam S; King Y; Foley L; Pasea L; Bond S; Palmer C; Deighton J; Ewan P; Clark A
Lancet; 2014 Apr; 383(9925):1297-1304. PubMed ID: 24485709
[TBL] [Abstract][Full Text] [Related]
7. Early Peanut Immunotherapy in Children (EPIC) trial: protocol for a pragmatic randomised controlled trial of peanut oral immunotherapy in children under 5 years of age.
O'Sullivan MD; Bear N; Metcalfe J
BMJ Paediatr Open; 2023 Nov; 7(1):. PubMed ID: 37963680
[TBL] [Abstract][Full Text] [Related]
8. Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy.
Kim EH; Perry TT; Wood RA; Leung DYM; Berin MC; Burks AW; Cho CB; Jones SM; Scurlock A; Sicherer SH; Henning AK; Dawson P; Lindblad RW; Plaut M; Sampson HA;
J Allergy Clin Immunol; 2020 Oct; 146(4):851-862.e10. PubMed ID: 32535135
[TBL] [Abstract][Full Text] [Related]
9. Early sustained unresponsiveness after short-course egg oral immunotherapy: a randomized controlled study in egg-allergic children.
Escudero C; Rodríguez Del Río P; Sánchez-García S; Pérez-Rangel I; Pérez-Farinós N; García-Fernández C; Ibáñez MD
Clin Exp Allergy; 2015 Dec; 45(12):1833-43. PubMed ID: 26236997
[TBL] [Abstract][Full Text] [Related]
10. Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study.
Chinthrajah RS; Purington N; Andorf S; Long A; O'Laughlin KL; Lyu SC; Manohar M; Boyd SD; Tibshirani R; Maecker H; Plaut M; Mukai K; Tsai M; Desai M; Galli SJ; Nadeau KC
Lancet; 2019 Oct; 394(10207):1437-1449. PubMed ID: 31522849
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
O'B Hourihane J; Beyer K; Abbas A; Fernández-Rivas M; Turner PJ; Blumchen K; Nilsson C; Ibáñez MD; Deschildre A; Muraro A; Sharma V; Erlewyn-Lajeunesse M; Zubeldia JM; De Blay F; Sauvage CD; Byrne A; Chapman J; Boralevi F; DunnGalvin A; O'Neill C; Norval D; Vereda A; Skeel B; Adelman DC; du Toit G
Lancet Child Adolesc Health; 2020 Oct; 4(10):728-739. PubMed ID: 32702315
[TBL] [Abstract][Full Text] [Related]
12. PrEggNut Study: protocol for a randomised controlled trial investigating the effect of a maternal diet rich in eggs and peanuts from <23 weeks' gestation during pregnancy to 4 months' lactation on infant IgE-mediated egg and peanut allergy outcomes.
Palmer DJ; Sullivan TR; Campbell DE; Nanan R; Gold MS; Hsu PS; Netting MJ; McWilliam V; Koplin JJ; Perrett KP; Quinn P; O'Sullivan M; Prescott SL; Grivell R; Makrides M
BMJ Open; 2022 Jun; 12(6):e056925. PubMed ID: 35697444
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.
Jones SM; Kim EH; Nadeau KC; Nowak-Wegrzyn A; Wood RA; Sampson HA; Scurlock AM; Chinthrajah S; Wang J; Pesek RD; Sindher SB; Kulis M; Johnson J; Spain K; Babineau DC; Chin H; Laurienzo-Panza J; Yan R; Larson D; Qin T; Whitehouse D; Sever ML; Sanda S; Plaut M; Wheatley LM; Burks AW;
Lancet; 2022 Jan; 399(10322):359-371. PubMed ID: 35065784
[TBL] [Abstract][Full Text] [Related]
14. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.
Vickery BP; Scurlock AM; Kulis M; Steele PH; Kamilaris J; Berglund JP; Burk C; Hiegel A; Carlisle S; Christie L; Perry TT; Pesek RD; Sheikh S; Virkud Y; Smith PB; Shamji MH; Durham SR; Jones SM; Burks AW
J Allergy Clin Immunol; 2014 Feb; 133(2):468-75. PubMed ID: 24361082
[TBL] [Abstract][Full Text] [Related]
15. The effect of oral immunotherapy treatment in severe IgE mediated milk, peanut, and egg allergy in adults.
Mäntylä J; Thomander T; Hakulinen A; Kukkonen K; Palosuo K; Voutilainen H; Pelkonen A; Kauppi P
Immun Inflamm Dis; 2018 Jun; 6(2):307-311. PubMed ID: 29542268
[TBL] [Abstract][Full Text] [Related]
16. Interaction Between Baseline Participant Factors and Treatment Effects Following Peanut Oral Immunotherapy.
Lloyd M; Loke P; Ashley S; Lozinsky AC; Orsini F; O'Sullivan M; Gold M; Quinn P; Metcalfe J; Tang MLK
J Allergy Clin Immunol Pract; 2024 Apr; 12(4):1019-1028.e2. PubMed ID: 38154554
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of oral immunotherapy for egg allergy in Japanese patients.
Akashi M; Yasudo H; Narita M; Nomura I; Akasawa A; Ebisawa M; Takahashi T; Ohya Y
Pediatr Int; 2017 May; 59(5):534-539. PubMed ID: 27914210
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of probiotic peanut oral immunotherapy (PPOIT) versus placebo in Australian children with peanut allergy alongside a randomised trial.
Huang L; Dalziel K; Lloyd M; Loke P; Lozinsky AC; Tang M
BMJ Open; 2023 Dec; 13(12):e075521. PubMed ID: 38072489
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and Safety of Double-Blind, Placebo-Controlled, Low-Dose Oral Immunotherapy with Low Allergen Egg-Containing Cookies for Severe Hen's Egg Allergy: A Single-Center Analysis.
Takaoka Y; Maeta A; Takahashi K; M Ito Y; Takahashi S; Muroya T; Shigekawa A; Tsurinaga Y; Iba N; Yoshida Y; Kameda M; Doi S
Int Arch Allergy Immunol; 2019; 180(4):244-249. PubMed ID: 31578023
[TBL] [Abstract][Full Text] [Related]
20. Oral and sublingual immunotherapy for egg allergy.
Romantsik O; Bruschettini M; Tosca MA; Zappettini S; Della Casa Alberighi O; Calevo MG
Cochrane Database Syst Rev; 2014 Nov; (11):CD010638. PubMed ID: 25405335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
